Psychiatric medication management for West Palm Beach — measurement-based, in-person.

RECO Integrated Psychiatry's Delray Beach office is 18 miles and 28 minutes down I-95 from El Cid, Flamingo Park, and Downtown WPB — the nearest specialty outpatient practice built around measurement-based psychiatric care rather than 15-minute refill visits. Initial evaluations run 60 to 90 minutes, produce a documented DSM-5-TR formulation, and are anchored to visit-scored PHQ-9, GAD-7, ASRS, and MDQ trajectories. The full pharmacologic algorithm is on the table — augmentation with aripiprazole or lithium, cross-class switching, pharmacogenomic testing, and escalation to rTMS or Spravato when outpatient pharmacology reaches its ceiling.

West Palm Beach sits 18 miles north of RECO Integrated Psychiatry’s Delray Beach office — a 28-minute run down I-95 or Federal Highway outside rush hour. For adults living in El Cid, Flamingo Park, Northwood Hills, SoSo, or Downtown WPB who need specialist-level psychiatric care without the disruption of a residential program, the Delray campus is the nearest outpatient practice built around measurement-based psychiatric medication management — DSM-5-TR formulation, visit-anchored PHQ-9 and GAD-7 scoring, and the full pharmacologic algorithm rather than a stopping point at sertraline plus bupropion.

What a real psychiatric evaluation actually covers

The initial visit at RECO runs 60 to 90 minutes and produces a documented DSM-5-TR diagnostic formulation, not a checklist of endorsed symptoms. History includes every prior medication trial with doses, durations, and the specific reason for discontinuation — side effect, non-response, tolerability, adherence, or cost — because a client who “failed sertraline” at 50 mg for three weeks has not actually had an adequate SSRI trial, and the record needs to reflect that.

Family psychiatric history is documented in the first-degree relatives. Substance use is screened with structured questions rather than a yes/no. Trauma history is taken where clinically relevant. Every adult presenting with “depression” or “anxiety” is screened for bipolarity (MDQ), ADHD (ASRS), and OCD (Y-BOCS), because unrecognized bipolar II presenting as recurrent depression is a common reason antidepressant monotherapy fails, and inattentive-presentation ADHD is routinely missed in adults treated for anxiety.

Baseline labs — CBC, CMP, TSH, B12, folate, vitamin D — are ordered where indicated. Hypothyroidism, B12 deficiency, and iron deficiency all produce psychiatric presentations that do not respond to psychotropics. This is the workup a 15-minute primary care visit does not have room to complete.

Measurement-based care and why it changes outcomes

PHQ-9 for depressive symptoms, GAD-7 for anxiety, MDQ for bipolar screening, ASRS for adult ADHD, Y-BOCS for OCD severity, PCL-5 for PTSD. Scales are completed before the visit and scored inside it, and the trajectory across visits is what anchors medication decisions. Published trial data across the STAR*D, CO-MED, and more recent measurement-based-care implementation studies is consistent: patients whose clinicians track quantified symptom scores achieve remission at meaningfully higher rates than those treated by clinical impression alone.

The practical consequence at RECO is that a client whose PHQ-9 has moved from 22 to 19 to 17 over eight weeks is treated as a partial responder — a signal to augment, dose-optimize, or reassess the diagnosis — rather than as someone who “feels a little better,” which is the reading that leads to years on a subtherapeutic regimen. Scale scores also identify the opposite failure mode: a client who reports feeling fine while the GAD-7 remains above 15 has residual pathology that will re-emerge under stress.

The pharmacologic toolkit beyond the first two SSRIs

First-line pharmacotherapy is uncontroversial. SSRIs and SNRIs — sertraline, escitalopram, venlafaxine, duloxetine — are appropriate for major depression and most anxiety disorders. Stimulants and non-stimulants (methylphenidate, amphetamine salts, atomoxetine, guanfacine) are appropriate for ADHD. Mood stabilizers and second-generation antipsychotics — lithium, lamotrigine, quetiapine, lurasidone, aripiprazole — are appropriate for bipolar disorder. SSRIs plus a referral for ERP are first-line for OCD.

The value of a specialty practice is what happens when first-line does not produce remission. Augmentation with aripiprazole, low-dose lithium, or T3 has replicated evidence in treatment-resistant depression. Cross-class switching, MAOI trials in genuinely refractory cases, and pharmacogenomic testing (GeneSight, Genomind) for clients with multiple failed trials or documented CYP2D6/2C19 variance are all part of the algorithm. When outpatient pharmacology reaches its ceiling, escalation to interventional treatment — rTMS at 3,000 pulses per session at 120% of motor threshold, or intranasal esketamine (Spravato) under REMS-compliant observation — is available in-network without a referral loop.

The failure pattern RECO’s psychiatrists exist to correct is the client who has been on sertraline, then escitalopram, then bupropion for six years and has never had an augmentation trial, a bipolar screen, or a serum lithium level considered.

Monitoring: the labs, the metabolic panel, the drug levels

Lithium requires baseline TSH, creatinine, and calcium, then periodic monitoring with quarterly serum levels and TSH and creatinine at six to twelve months. Atypical antipsychotics — quetiapine, olanzapine, aripiprazole, risperidone — require baseline weight, waist circumference, blood pressure, fasting glucose or HbA1c, and lipid panel, repeated at three months and then annually per APA guidance. Valproate requires baseline LFTs, CBC with platelets, and serum levels once steady state is reached.

Stimulants require documented cardiovascular history, resting blood pressure, and pulse at every visit, with EKG where indicated. Clozapine, when it is on the table, requires the full ANC monitoring cadence under REMS. These are not optional add-ons — they are the standard of care, and they are built into RECO’s visit templates so that nothing gets missed because the client did not know to ask.

What to expect on your first visit

Intake paperwork and baseline scales — PHQ-9, GAD-7, ASRS, MDQ, PCL-5 — are completed before arrival. The evaluation itself is 60 to 90 minutes with the psychiatrist. Records from prior prescribers, hospitalizations, and outside therapists are requested in advance so the visit is not spent reconstructing a history the chart already contains.

Most clients leave the first visit with a working DSM-5-TR formulation, a written medication plan, any labs ordered, and a follow-up scheduled at two to four weeks depending on what was started or changed. Adjunctive psychotherapy — CBT, DBT skills, EMDR for trauma, ACT for chronic anxiety, motivational interviewing where indicated — is coordinated in-house or with vetted community providers.

Insurance and admissions from West Palm Beach

RECO Integrated Psychiatry is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. Benefits verification runs before the first appointment so the client knows their copay, deductible position, and whether the plan requires prior authorization for any specific agents — most commonly stimulants, esketamine, and pharmacogenomic testing. Self-pay rates are published rather than quoted on request.

Scheduling from West Palm Beach neighborhoods is straightforward: I-95 south to Linton Boulevard is the standard route, roughly 28 minutes outside rush. Telepsychiatry follow-ups are available for stable clients after the initial in-person evaluation, which the DEA telehealth rules and Florida licensure both permit for established patients.

Serving residents of: El Cid, Flamingo Park, Northwood Hills, SoSo, Downtown WPB.